Allergy Therapeutics plc (AIM:AGY)
5.80
+0.10 (1.75%)
Apr 17, 2025, 4:35 PM GMT+1
Allergy Therapeutics Employees
Allergy Therapeutics had 612 employees as of June 30, 2023. The number of employees decreased by 10 or -1.61% compared to the previous year.
Employees
612
Change (1Y)
-10
Growth (1Y)
-1.61%
Revenue / Employee
90.94K GBP
Profits / Employee
-58.25K GBP
Market Cap
276.45M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Oxford Nanopore Technologies | 1,315 |
Allergy Therapeutics News
- 4 months ago - SMALL CAP IDEA: Allergy Therapeutics transformation has redefined its trajectory - This is Money
- 10 months ago - Global Allergy Therapeutics Market Size To Exceed USD 42.5 Billion By 2033 | CAGR Of 6.29% - GlobeNewsWire
- 3 years ago - Allergy Therapeutics announces FDA clearance of IND application for novel peanut allergy vaccine candidate VLP Peanut - GlobeNewsWire
- 4 years ago - Allergy Therapeutics reports a 6% annualised growth in revenue in fiscal 2020 - Invezz